$VRX Valeant Pharmaceuticals bonds were much more stable than bonds during turmoil started Sept 2015. The common stock is down nearly 67% while the 5.625% bond (144A) due 2021 is down only 5%.
+1 (1)
George Walker 04:14 PM 03/24/2016
$VRX Aswath Damodaran: Valeant is too complex for value investors #sell
+2 (2)
5
David Lyons 01:16 PM 03/22/2016
$VRX ... and billionaire investor William Ackman would join the board #bullish
$VRX John Paulson increased his holdings in Valeant Pharma by 49.22% in the fourth quarter, now owning $1.35 billion worth of the company, contributing to over 8% of his total holdings.
+1 (1)
5
Barry Gardiner 04:16 PM 01/19/2016
$VRX Please pay attention that ROC is at 6.2% only, so all the profits couldn't be profitably reinvested... #neutral
+1 (1)
5
Barry Gardiner 09:12 AM 01/18/2016
$VRX 8.9x Next Year EV/EBITDA, 27% expected this year growth, 20% FY2016E revenue growth, EBITDA margin at 46% while CAPEX/Revenue only at 3.5% - cheap for the expected growth! #buy
5
Robert Sheridan 04:18 PM 11/19/2015
$VRX well-run company with double-digit growth - Valeant is quite an attractive investment in Canada stock universe! #buy
$VRX Of the 25 tracked by Bloomberg, 18 still have buy ratings on Valeant shares. Another six rate the stock a hold, while only one, Dimitry Khmelnitsk at Veritas Investment Research, rates it a sell.
Lisa Hoppe 01:14 PM 10/22/2015
$VRX research #3 from Citron Research "Now Valeant has made new disclosures regarding its distribution channel, and they’ve led the company into a web of deception that … you have to read for yourselves." www.citronresearch.com/va...l-enron/
Lisa Hoppe 12:56 PM 10/03/2015
$VRX Citron Research published research #2 on Valeant "Investors, Politicians, and Concerned Citizens must note that Valeant raised the prices on the two key heart drugs in question the very next day after they acquired them … just to cover up for a bad quarter." www.citronresearch.com/ci...valeant/
5
David Lyons 12:01 PM 09/29/2015
$VRX heh... time to #sell the stocks don't recover at least for 6-12m after Citron research... or never recover!
Lisa Hoppe 11:36 AM 09/29/2015
$VRX BOOM... Citron Research published a research on Valeant. "As well as a major threat to the integrity of our entire healthcare system, Valeant (NYSE:VRX) is now the most devious three-cornered tax avoidance scheme we've ever seen." #sellwww.citronresearch.com/wh...granted/
5
John O'Donoghue 07:46 AM 08/21/2015
$VRX Valeant buys “female Viagra” maker Sprout but market is not aroused #bullish
Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders; and distributes generic and branded generic drugs in Latin America and Eastern Europe.
